University of Pennsylvania Treatment Research Center to begin phase II study of NS-2359 Dec. 22, 2015
FDA approves Vistogard to treat overdose or severe toxicities due to 5-FU or capecitabine Dec. 14, 2015
Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS Dec. 7, 2015
RSS